Time-varying dynamics of hepatic steatosis and cardiometabolic risk: implications for posthepatitis C cure HCC risk.
0/5 보강
APA
Chang YP, Chen YC, Liu CH (2026). Time-varying dynamics of hepatic steatosis and cardiometabolic risk: implications for posthepatitis C cure HCC risk.. Gut. https://doi.org/10.1136/gutjnl-2026-338554
MLA
Chang YP, et al.. "Time-varying dynamics of hepatic steatosis and cardiometabolic risk: implications for posthepatitis C cure HCC risk.." Gut, 2026.
PMID
41760386
같은 제1저자의 인용 많은 논문 (3)
- Risk Scores for Stratifying Hepatocellular Carcinoma and Optimizing Surveillance Strategies.
- Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease.
- Serum Mac-2 binding protein glycosylation isomer in predicting hepatocellular carcinoma occurrence among patients with direct-acting antiviral-induced HCV cure.